Functional characterization of SDHB variants: Advancing succinate dehydrogenase biology and variant curation in hereditary paraganglioma
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci202727 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Roderick Clifton-Bligh. Beteiligte Einrichtung: Department of Endocrinology, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, New South Wales, Australia. Hauptthemen laut MEDLINE: Succinate Dehydrogenase, Paraganglioma, Germ-Line Mutation, Adrenal Gland Neoplasms. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, New South Wales, Australia.
- School of Medicine, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Zitieren
APA
Clifton-Bligh, R. (2026). Functional characterization of SDHB variants: Advancing succinate dehydrogenase biology and variant curation in hereditary paraganglioma. Journal of Clinical Investigation. https://doi.org/10.1172/jci202727
Vancouver
Clifton-Bligh R. Functional characterization of SDHB variants: Advancing succinate dehydrogenase biology and variant curation in hereditary paraganglioma. Journal of Clinical Investigation. 2026. doi:10.1172/jci202727
BibTeX
@article{CliftonBligh2026,
author = {Clifton-Bligh, Roderick},
title = {Functional characterization of SDHB variants: Advancing succinate dehydrogenase biology and variant curation in hereditary paraganglioma},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci202727}
}
EUVIMED